


To achieve capital growth whilst maintaining a reasonable yield through a diversified Investments largely in equity markets with a bias towards UK and international equities, fixed income securities issued by governments, corporations and bank deposits.
| Name | % Net Assets |
|---|---|
| BP | 6.3% |
| HSBC | 5.4% |
| GlaxoSmithKline | 4.1% |
| Standard Chartered | 4.0% |
| BP | 3.6% |
| Unilever | 3.5% |
| Imperial Tobacco | 3.5% |
| BG | 3.2% |
| BHP Billiton | 3.0% |
| Anglo American | 2.8% |
| Key | % Net Assets |
|---|---|
| 6.3% | |
| 5.4% | |
| 4.1% | |
| 4.0% | |
| 80.2% |
| Date | 19-Aug-2025 |
|---|---|
| NAV | 313.44p |
| Currency | GBP |
| Change | 0.61p |
| % | 0.20% |
| YTD change | 11.64p |
| YTD % | 3.86% |
| Fund Inception | 01/06/1999 |
|---|---|
| Fund Manager | n/a |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 0.75% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research